USD 2.44 billion Growth in Travel Vaccines Market Size with 42% of the contribution from North America

USD 2.44 billion Growth in Travel Vaccines Market Size with 42% of the contribution from North America

USD 2.44 billion Growth in Travel Vaccines Market Size with 42% of the contribution from North America

NEW YORK, Aug. 22, 2022 /PRNewswire/ — The newest market evaluation report titled Travel Vaccines Market by Disease Type and Geography – Forecast and Analysis 2022-2026 has been just lately added to Technavio’s catalog. The report analysts have categorized the world journey vaccines market as an element of the world prescription drugs market. Our report gives intensive data on the worth chain evaluation for the journey vaccines market, which distributors can leverage to realize a aggressive benefit throughout the forecast interval. The knowledge obtainable in our worth chain evaluation phase might help distributors drive prices and improve buyer providers throughout the forecast interval. One of the key elements driving the world journey vaccines market progress is the improve in world journey and migration. In addition, modifications in the demographic profile of vacationers globally are one of the key journey vaccines market developments which might be anticipated to impression the trade positively in the forecast interval. However, the absence of protection for journey vaccines in many well being plans is anticipated to restrict the market’s progress throughout the forecast interval.

Latest market analysis report titled Travel Vaccines Market by Disease Type and Geography – Forecast and Analysis 2022-2026 has been introduced by Technavio which is proudly partnering with Fortune 500 corporations for over 16 years

For market scope, worth chain evaluation, and key market dynamics, Read a FREE Sample

Travel Vaccines Market Segmentation Highlights

For extra segment-based insights and regional alternatives, Request for Sample Report

  • The journey vaccines market is fragmented and the distributors are deploying progress methods comparable to funding in R&D to compete in the market. The journey vaccines market forecast report affords in-depth insights into key vendor profiles. The profiles embody data on the manufacturing, sustainability, and prospects of the main corporations.

  • Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE are some of the main market contributors.

  • To make the most of the alternatives, market distributors ought to focus extra on the progress prospects in the fast-growing segments, whereas sustaining their positions in the slow-growing segments.

  • Vendors are providing a variety of choices to realize a aggressive edge in the market. For occasion, CSL Ltd. affords the broadest influenza vaccine and a variety of vaccines and specialty medicines that meet distinctive, native public well being wants. Bharat Biotech Ltd. affords journey vaccines comparable to BioHib, a lyophilized vaccine that’s used for growth primarily based on an Indian pressure.

  • Backed with aggressive intelligence and benchmarking, our analysis reviews on the journey vaccines market are designed to supply entry help, buyer profile, and M&As in addition to go-to-market technique help.

More vendor choices and their strategic initiatives can be found in this PDF Sample Report

Travel Vaccines Market Scope

Technavio presents an in depth image of the market by manner of research, synthesis, and summation of knowledge from a number of sources. Our journey vaccines market report covers the following areas:

Travel Vaccines Market Highlights

  • CAGR of the market throughout the forecast interval 2022-2026

  • Detailed data on elements that may help journey vaccines market progress throughout the subsequent 5 years

  • Estimation of the journey vaccines market dimension and its contribution to the mother or father market

  • Predictions on upcoming developments and modifications in shopper habits

  • The progress of the journey vaccines market

  • Analysis of the market’s aggressive panorama and detailed data on distributors

  • Comprehensive particulars of elements that may problem the progress of journey vaccines market distributors

Related Reports:

Vaccines Market by Type and Geography – Forecast and Analysis 2022-2026

Human Combination Vaccines Market by Type and Geography – Forecast and Analysis 2021-2025

Therapeutic Vaccines Market by Type and Geography – Forecast and Analysis 2020-2024

Foot and Mouth Disease Vaccines Market by Product and Geography – Forecast and Analysis 2021-2025

Travel Vaccines Market Scope

Report Coverage

Details

Page quantity

120

Base yr

2021

Forecast interval

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 8.59%

Market progress 2022-2026

$2.44 billion

Market construction

Fragmented

YoY progress (%)

7.85

Regional evaluation

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 42%

Key shopper international locations

US, Germany, UK, Japan, and China

Competitive panorama

Leading corporations, aggressive methods, shopper engagement scope

Companies profiled

Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE

Market Dynamics

Parent market evaluation, market progress inducers and obstacles, fast-growing and slow-growing phase evaluation, COVID 19 impression and future shopper dynamics, and market situation evaluation for the forecast interval.

Customization purview

If our report has not included the knowledge that you’re on the lookout for, you may attain out to our analysts and get segments custom-made.

Table Of Contents:

1 Executive Summary

2 Market Landscape

3 Market Size

4 Five Forces Analysis

5 Market Segmentation by Disease Type

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Us

Technavio is a number one world know-how analysis and advisory firm. Their analysis and evaluation deal with rising market developments and supply actionable insights to assist companies establish market alternatives and develop efficient methods to optimize their market positions. With over 500 specialised analysts, Technavio’s report library consists of greater than 17,000 reviews and counting, overlaying 800 applied sciences, spanning 50 international locations. Their shopper base consists of enterprises of all sizes, together with greater than 100 Fortune 500 corporations. This rising shopper base depends on Technavio’s complete protection, intensive analysis, and actionable market insights to establish present alternatives in and potential markets and assess their aggressive positions inside altering market situations.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Technavio (PRNewsfoto/Technavio)

Technavio (PRNewsfoto/Technavio)

Cision

Cision

View unique content material to obtain multimedia: https://www.prnewswire.com/news-releases/usd-2-44-billion-growth-in-travel-vaccines-market-size-with-42-of-the-contribution -from-north-america—technavio-301609618.html

SOURCE Technavio

Leave a Reply

%d bloggers like this: